# GPT-5.2 Review

**Role:** External referee review
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-03-04T14:00:15.597970
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 16502 in / 4902 out
**Response SHA256:** 4709aacc2a1870eb

---

## Summary

The paper asks whether France’s **Action Cœur de Ville (ACV)** program raised residential property values in targeted medium-sized city centers. Using DVF universe transaction data (2014–2025) and a DiD comparing ACV communes to non-ACV communes within the same département, the paper reports:

- **Commune-year mean price/m²** increases of about **6–7%** post-2018 (Table 2, cols. 2–3).
- **Transaction-level hedonic DiD** estimates near zero once controlling for basic characteristics (Table 2, cols. 5–6), interpreted as a **composition** story.
- Event-study “flat pre-trends,” and placebo tests using fake treatment years.

The topic is important and the data are strong, but in its current form the paper is **not publication-ready for a top general-interest journal** because the identifying variation is fragile given (i) an arguably inappropriate control group, (ii) extensive **missing pre-period exposure** for many treated communes and selection into having transactions, (iii) timing/intensity heterogeneity that is currently collapsed into a single “Post ≥ 2018” indicator, and (iv) the coincidence of estimated effects with COVID-era spatial demand shifts that are not convincingly ruled out with the present design. In addition, the key “composition vs capitalization” interpretation is plausible but not yet demonstrated with the rigor required for the paper’s strong conclusions.

Below I focus on scientific substance and publication readiness (not prose or figure aesthetics).

---

# 1. Identification and empirical design (critical)

### 1.1 Core DiD design: control group comparability is a first-order concern
The paper samples controls “randomly” within the same départements (Data Appendix; §3, §4.1). The resulting control group is **structurally different** from treated communes:

- Pre-period transactions/year: **179 (ACV) vs 12 (controls)** (Table 1).
- Apartment share: **44% vs 11%** (Table 1).

This is not a cosmetic imbalance: it strongly suggests treated units are **urban centers** and controls are largely **small towns/rural communes**. Commune fixed effects remove level differences, but they do **not** guarantee parallel trends when the underlying markets have different exposure to secular forces (urbanization, amenities, credit constraints, remote work, tourism, migration, etc.). In particular, any shocks that differentially affect “urban centers vs rural/peripheral” within a département can violate parallel trends even with département-by-year FE.

**Why this matters:** In a top journal, DiD credibility hinges on a control group that plausibly shares the same counterfactual trend. Here, the control group appears to represent a different market segment, making “within-département” too coarse a restriction.

**Concrete fix:** Rebuild the counterfactual using a transparent, ex ante rule that targets *comparable* communes:
- Construct a candidate donor pool of communes that are **préfecture/sous-préfecture**, “unités urbaines” of similar population, or communes in the same **urban area (aire d’attraction)** tier.
- Match/reweight on pre-2018 levels *and trends* of: price/m², transaction volume, apartment share, population, income, vacancy, employment, distance to large metro, coastal dummy, etc. (INSEE provides much of this).
- Show overlap diagnostics and robustness across alternative donor definitions (e.g., within region; within commuting zone; excluding coastal/touristic communes; excluding peri-metropolitan communes).

### 1.2 Treated sample has severe pre-period missingness; this threatens identification
A key line in §3.4 and Table 1 notes: **only 107 of 230 treated communes have any pre-period transactions** (2014–2017). The paper states FE estimators drop singleton communes, reducing observations (Table 2 notes), but the implications are deeper:

- The estimated DiD in Table 2 col. (2) is effectively identified off the subset with pre/post variation (and those with transactions in both periods).
- Entry into the DVF sample (having ≥1 transaction) is itself potentially **affected by ACV** (you even show transaction volume increases). Conditioning on observing transactions can induce **post-treatment selection**.

**Why this matters:** When the dependent variable is a transaction-based mean, missing commune-years are not innocuous “missing data”; they are an outcome-linked selection process. If ACV increases transactions in previously illiquid markets, the set of observed commune-years changes endogenously, biasing both levels and dynamics.

**Concrete fix:** You need an explicit strategy for “no transaction” commune-years:
- Preferably move to a design that does **not** condition on transaction incidence, e.g.:
  - Construct repeat-sales indices (where feasible) or commune-year price indices using hedonic imputation methods that define an index even with small samples (with measurement-error modeling).
  - Alternatively, treat commune-years with no transactions as missing but then show robustness using **balanced panels** (communes with transactions in all pre years and at least X post years), and report how estimates change.
- At minimum:
  - Report counts of commune-years with zero transactions by treatment status and year (pre/post).
  - Show results on increasingly strict “liquidity” subsamples (e.g., communes with ≥20 transactions/year pre; ≥10/year; etc.).
  - Use **inverse-probability weighting** or selection corrections where the first stage models the probability of observing a price (having transactions).

### 1.3 Treatment timing and exposure intensity are collapsed too aggressively
ACV is not a sharp intervention in 2018; conventions sign from late 2018 onward, ramping through 2020–2022 (§2.4). Moreover, **22 communes join later**, yet the paper codes them treated starting 2018 (§4.1 footnote).

Even if you argue this biases toward zero, coding “ever treated” as treated from 2018 can also **distort dynamics** and complicate interpretation of the event study, especially because your estimated effects start in 2020 (coinciding with actual ramp-up *and* COVID).

**Concrete fix:**
- Use actual **convention signing dates** (you have them) to define treatment adoption, then apply modern staggered DiD/event-study estimators (Callaway–Sant’Anna; Sun–Abraham) *even if most adoption is in one cohort*. This will:
  - Separate “2018 cohort” from later adopters,
  - Clarify dynamics around adoption,
  - Avoid contamination from mis-timing.
- Additionally, create a **dose/intensity** proxy:
  - At minimum, “signed convention by year t” and “years since signing.”
  - Better: commune-level committed amounts or project counts (ANCT/CDC/ANAH may have project-level administrative data). A top outlet will expect serious effort to measure intensity given ACV’s heterogeneous implementation.

### 1.4 COVID-era confounding is not convincingly addressed
You acknowledge that the effect emerges in 2020 (event study, §5.2; discussion §7.3). Département-by-year FE absorb *regional* COVID shocks, but not shocks that differentially affect **city centers of medium-sized towns** relative to surrounding rural communes within the same département (which is exactly your treated-control contrast, per Table 1).

In other words, the remaining confound is a **within-département “urban-center vs periphery” COVID/remote work shock**, which département-by-year FE does not remove.

**Concrete fix:** You need designs/tests that speak directly to this:
- Use controls that are *also* medium-sized urban centers but **not treated** (see 1.1).
- Triple-difference:
  - Compare ACV-eligible cities to similar non-ACV cities, before/after 2018, and interact with **COVID intensity** or remote-work feasibility exposure.
- Exploit buyer-origin data if available (DVF may not have it; notaires databases sometimes do). If not:
  - Use commune-level migration/registration proxies, mobile phone mobility, or tax address change aggregates if obtainable.
- Show that the effect is present in periods where COVID demand shifts should have attenuated (e.g., 2023–2024), but this alone is not decisive without a better counterfactual.

---

# 2. Inference and statistical validity (critical)

### 2.1 Standard errors and clustering
You cluster at the commune level throughout (Table 2 notes). With ~943 communes, asymptotics are likely fine for cluster-robust SE *if* the identifying variation is not dominated by a small subset of clusters.

However, two issues remain:

1. **Panel outcome precision varies massively by commune-year** (ACV communes have far more transactions than controls). Your dependent variable is an estimated mean from varying sample sizes, producing **heteroskedastic measurement error** at the commune-year level.
2. Transaction-level regressions with commune-level clustering are standard, but the transaction-level specifications (Table 2 cols. 5–6) likely require attention to:
   - **Multi-way clustering** (commune and year) or **spatial correlation** if shocks are spatially correlated within département/region.
   - Weighting/structure if there is serial correlation across years at the commune level (Bertrand–Duflo–Mullainathan issues).

**Concrete fix:**
- Commune-year regressions: implement **WLS** weighting by the number of transactions used to form the mean (or model the variance explicitly), and show robustness to unweighted OLS.
- Consider **wild cluster bootstrap** p-values (commune-level) for key coefficients as a robustness check.
- Consider two-way clustering (commune × year) or département-level clustering in the panel, and spatial HAC as sensitivity (at least show clustering at département as a robustness bound).

### 2.2 Event-study inference and pre-trend testing
You state pre-coefficients are “jointly insignificant” (Appendix; §5.2), but you do not report:
- The exact F-stat, degrees of freedom, or p-value,
- Whether you use **unbalanced** event-study samples, and how missing commune-years affect it.

**Concrete fix:** Report a table of event-study coefficients with SEs and the joint pre-trends test, and show robustness:
- Balanced sample,
- Alternative omitted year,
- Aggregation to pre-period bins.

### 2.3 Staggered DiD concerns
You argue TWFE issues are “not operative” because ACV is single-cohort (§6.3), but your own description contradicts strict single-cohort adoption (22 later additions; gradual signing; heterogeneous ramp-up). Even if you keep an “intent-to-treat” design, modern DiD estimators can still matter for event-study interpretation when adoption is not perfectly synchronized.

**Concrete fix:** Re-estimate key results using Callaway–Sant’Anna with cohort = signing year (or designation year), and present group-time ATT and aggregated ATT.

---

# 3. Robustness and alternative explanations

### 3.1 Placebos are helpful but too limited for the main threats
Fake post years (2015/2016) restricted to 2014–2017 (Table 3; §6.1) are useful checks for differential pre-trends. They do **not** address:
- COVID-induced differential trends starting 2020,
- Endogenous changes in transaction composition/volume affecting the commune-level mean,
- Control-group mismatch (urban vs rural) where pre-2018 trends can still be similar but post-2020 diverge for reasons unrelated to ACV.

**Concrete fix:** Add falsification outcomes and comparisons tailored to those threats:
- Outcomes plausibly insensitive to ACV but sensitive to COVID (or vice versa).
- A placebo treatment on **non-eligible** large metros or on outcomes like agricultural land prices (you mention “placebo outcomes” in §4.3.1 but do not show results).

### 3.2 Composition vs capitalization: interpretation is plausible but not yet identified
The central interpretive claim is that the commune-level mean price increase is driven by **composition shifts**, because transaction-level hedonic DiD is ~0 once controlling for log area and a house/apartment indicator (Table 2 cols. 5–6; §5.1, §5.5).

This is not sufficient to establish the composition mechanism because:
- Housing quality changes (renovation) are not observed; a renovated apartment is a different product. If ACV increases the share of *higher-quality* apartments sold, then a specification controlling only for area and type will still miss that compositional upgrading.
- Commune FE in transaction regressions do not “absorb renovation improvements” as stated in §5.5—renovation effects vary over time within commune and should load on the treatment if captured by price, unless they are fully captured by changing observables (they are not).
- The commune-level mean could rise because the set of transacted units changes toward higher-quality units, which is indeed a composition effect—but then your welfare/policy interpretation differs materially from “no price capitalization.”

**Concrete fix:**
- Implement a formal **Oaxaca–Blinder / DiNardo–Fortin–Lemieux reweighting decomposition** of the change in mean log price into:
  - composition of observables (type, size, location within commune if you can),
  - and “price schedule” changes (hedonic coefficients).
- Enrich hedonic controls:
  - finer property types, age proxies if available, number of rooms (DVF has limited features; consider merging with cadastral/MAJIC or EPC/DPE energy ratings if possible).
  - geocoded neighborhood fixed effects (e.g., IRIS×year FE) if data support it, which would also align better with “city center” targeting rather than commune-wide averages.
- Consider repeat-sales for a subset to isolate within-unit appreciation.

### 3.3 Spillovers and SUTVA
You note spillovers could bias toward zero (§4.3.3), but the control sampling within département likely includes **nearby communes** that are economically tied to the ACV city. This is not only attenuation; it can also induce complicated general equilibrium patterns (substitution vs complementarity in demand).

**Concrete fix:** Define controls by distance bands:
- Exclude communes within X km of treated centers (donut).
- Alternatively, explicitly estimate spillovers by distance to nearest treated ACV commune.

### 3.4 External validity and policy interpretation
The paper is careful in places, but several statements still lean too strongly causal given unresolved confounds (notably COVID and control mismatch). Also, ACV targets **city centers**, yet outcomes are at the **commune** level; many communes are large and heterogeneous.

**Concrete fix:** Where possible, move the unit to a tighter geography:
- Transactions within a “center” polygon/buffer (e.g., within 1–2 km of mairie, historic center, or defined ACV perimeter if obtainable).
- Compare within-commune center vs periphery (a within-commune triple-diff), which would substantially strengthen identification.

---

# 4. Contribution and literature positioning

### 4.1 Contribution is potentially strong but needs tighter positioning
“First rigorous causal evaluation of ACV” is plausible, and the administrative DVF universe is valuable. But to clear AER/QJE/JPE/ReStud/Ecta/AEJ:Policy, the paper needs a more credible design and clearer mapping to existing evidence on place-based interventions and housing markets.

### 4.2 Key literatures/papers to add or engage more directly
On DiD/event studies and identification in policy timing:
- Bertrand, Duflo, Mullainathan (2004) on DiD serial correlation.
- Goodman-Bacon (2021) decomposition of TWFE DiD (even if you argue single cohort).
- Roth (2022) on pretrends power and interpretation in event studies.
- Callaway & Sant’Anna (2021); Sun & Abraham (2021) you cite; consider also de Chaisemartin & D’Haultfœuille (2020) as another modern DiD.

On place-based policy and housing capitalization mechanisms:
- Kline & Moretti (2014) you cite; also Kline (2010) on TVA as place-based with spatial equilibrium framing.
- Ahlfeldt et al. (2015) you cite for structural spatial equilibrium—consider connecting more explicitly to spatial equilibrium logic (Roback-style) and what “composition” implies for welfare.
- Recent work on Opportunity Zones and housing markets (e.g., Sage, Larrimore, and others—depending on the closest empirical analogue) could help benchmark.

On COVID and housing spatial reallocation:
- There is now a large literature documenting pandemic-driven demand shifts; the paper should cite and use it to motivate explicit tests, not only acknowledge it as a limitation.

---

# 5. Results interpretation and claim calibration

### 5.1 Main causal claim currently overreaches given design limitations
The paper states it finds ACV “increased commune-level average residential prices by 6 to 7 percent” (Abstract; Conclusion). Given the control mismatch and COVID coincidence, a more defensible statement at present is closer to:
- “ACV-designated communes experienced a relative increase in transaction-based average prices vs sampled within-département controls, emerging around 2020.”

Until the paper rules out within-département “urban center” demand shocks and selection into transaction observation, the causal interpretation remains tentative.

### 5.2 The “composition rather than capitalization” claim needs sharper logic
Your current evidence supports “hedonic price of a coarse bundle didn’t change,” but not necessarily “no capitalization.” If ACV improves unobserved quality, the hedonic regression without quality controls will not detect it as capitalization if improvements manifest as *different units being sold*.

**Concrete fix:** Reframe and quantify:
- “Aggregate transaction-weighted mean increased; constant-quality price index did/did not change under various definitions of quality.”

---

# 6. Actionable revision requests (prioritized)

## 1) Must-fix issues before acceptance

1. **Reconstruct the control group to be plausibly comparable**
   - **Why:** Current control group appears rural/small-commune; parallel trends is not credible for post-2020 shocks.
   - **Fix:** Matching/reweighting on pre-trends and urban characteristics; restrict to similar urban centers; show robustness across donor definitions.

2. **Address missing pre-period transactions and selection into observed prices**
   - **Why:** Most treated communes lack pre data; conditioning on transactions can bias estimates when treatment affects liquidity.
   - **Fix:** Explicit handling of zero-transaction commune-years; balanced-panel robustness; methods that do not condition on transaction incidence, or selection modeling.

3. **Use actual treatment timing (designation/signing) and modern DiD where appropriate**
   - **Why:** Mis-timing (22 later) and ramp-up undermine event-study interpretation; not truly single-cohort in exposure.
   - **Fix:** Cohort-by-signing-year ATTs (Callaway–Sant’Anna / Sun–Abraham); event studies aligned to signing.

4. **Directly test and/or difference out COVID-era within-département “urban center” shocks**
   - **Why:** Effects begin in 2020; département-by-year FE does not solve within-département urban/periphery divergence.
   - **Fix:** Better controls; triple-diff with center/periphery within communes; interactions with remote-work exposure; distance-based analyses.

## 2) High-value improvements

5. **Move geography closer to the policy target (city center)**
   - **Why:** ACV targets centers; commune aggregates dilute and invite confounding.
   - **Fix:** Use geocoded transactions to define center buffers/perimeters; estimate center vs non-center within the same commune.

6. **Formal decomposition of “composition vs price schedule”**
   - **Why:** The main interpretive contribution hinges on this claim.
   - **Fix:** DFL/Oaxaca decompositions; richer hedonic controls; repeat-sales subset.

7. **Strengthen inference and robustness**
   - **Why:** Commune-year means have varying precision; need robustness in SE and weighting.
   - **Fix:** WLS by transaction counts; wild bootstrap; multi-way clustering; report sensitivity.

## 3) Optional polish (once core credibility is fixed)

8. **Dose-response / heterogeneity by intensity**
   - **Why:** ACV is heterogeneous; intensity results would increase policy relevance.
   - **Fix:** Use spending/project measures; estimate marginal effects.

9. **Clarify welfare/policy implications consistent with composition findings**
   - **Why:** Composition shifts have ambiguous incidence; connect to spatial equilibrium logic.
   - **Fix:** Temper claims; outline what additional data would identify welfare.

---

# 7. Overall assessment

### Key strengths
- Important policy question with high external interest (place-based revitalization in Europe).
- Excellent administrative data source (DVF universe) with long horizon (2014–2025).
- Transparent baseline DiD and clear empirical motivation.
- The “composition vs constant-quality price” angle is promising and could become a distinctive contribution.

### Critical weaknesses
- Control group construction (random within département) yields a comparison that is likely **not a valid counterfactual**, especially post-2020.
- Severe pre-period missingness for treated communes and endogenous selection into “observed price.”
- Treatment timing/intensity heterogeneity not integrated into the empirical strategy.
- COVID-era confounding remains a central unresolved threat.
- Mechanism interpretation not yet supported by formal decomposition/constant-quality measurement.

### Publishability after revision
Potentially publishable with a **substantially strengthened design**—especially if you (i) define “city centers” and use within-commune contrasts, and/or (ii) build a truly comparable control group of similar urban centers with transparent matching/reweighting, and (iii) handle transaction-selection explicitly. Without those changes, the paper is unlikely to meet the evidentiary bar of the listed journals.

DECISION: MAJOR REVISION